AMPK is both a tumour suppressor, responsible for a cytostatic effect when activated, and a protector of tumour cells, allowing them to survive in a hostile environment for extended periods of time, which occurrs during development of solid tumours [59, 60]. Here, PRKAA2 is linked to neoplasm.